This site uses cookies. By continuing to use the site, you agree to our use of cookies. Learn more about how we use cookies. Read more
Ok
Arkiv
2020-09-25
NeoDynamics is approaching launch of new pulse biopsy system NeoNavia - reputed international gynecologists and radiologists gained positive hands-on experience
Weiterlesen
2020-08-21
Regulatory
NeoDynamics AB (publ) Half year report 2020
Weiterlesen
2020-07-06
Regulatory
NeoDynamics establishes reference centres in Germany to support the introduction of its novel pulse biopsy system NeoNavia and optimize the diagnosis of breast cancer
Weiterlesen
2020-07-06
Regulatory
NeoDynamics restarts patient recruitment to UK COMPULSE Study to optimize diagnosis of breast cancer
Weiterlesen
2020-05-26
Regulatory
NeoDynamics AB (publ) First Quarter 2020
Weiterlesen
2020-02-05
Regulatory
NeoDynamics AB (publ) full-year report 2019
Weiterlesen
2020-02-03
A clinical study performed at Karolinska Hospital with NeoDynamics’ new biopsy system, NeoNavia, has been accepted as an abstract by the Society for Breast Imaging (SBI) in the US.
Weiterlesen
2020-01-28
NeoDynamics AB (publ) receives notification of granted patent on biopsy instrument in China
Weiterlesen
2019-11-27
NeoDynamics signs manufacturing agreement for NeoNavia
Weiterlesen
2019-11-21
Regulatory
NeoDynamics AB (publ) Third quarter Jul-Sep 2019
Weiterlesen
2019-11-05
For the first time in UK, a wider audience can get first-hand experience of the NeoNavia® micropulse biopsy system for breast cancer
Weiterlesen
2019-10-29
Regulatory
NeoDynamics receives regulatory approval for new breast cancer biopsy system
Weiterlesen
2019-09-16
NeoDynamics recruits a country manager for Germany, Switzerland and Austria
Weiterlesen
2019-08-28
Regulatory
NeoDynamics has secured financing through the issue of convertibles and calls for an Extraordinary General Meeting
Weiterlesen
2019-08-28
Regulatory
NeoDynamics Half-year report 2019
Weiterlesen
2019-08-15
New date for NeoDynamics semi-annual report 2019
Weiterlesen
2019-05-22
Regulatory
NeoDynamics AB (publ) invests in biopsy instrument for more effective sampling of suspected skin cancer
Weiterlesen
2019-05-21
Regulatory
NeoDynamics AB (publ) - Quarterly report January-March 2019
Weiterlesen
2019-04-26
Regulatory
NeoDynamics AB (publ) receives advance notice from U.S. Patent Office for a granted biopsy instrument patent
Weiterlesen
2019-04-10
New breast biopsy device is evaluated at Karolinska University Hospital in Stockholm
Weiterlesen
2019-02-21
Regulatory
Year-end report 2018 - NeoDynamics
Weiterlesen
2019-02-18
New Swedish technology for breast cancer diagnosis tested by leading experts in Germany
Weiterlesen
2018-12-07
NeoNavia commercial version fully integrated according to plan
Weiterlesen
2018-12-07
First day of trading in NeoDynamics’ shares and warrants on Spotlight Stock Market
Weiterlesen
2018-11-19
Regulatory
NeoDynamics’ issue of units prior to planned listing on Spotlight Stock Market fully subscribed
Weiterlesen
2018-11-12
NeoDynamics participates on Stora Aktiedagen and in a Live Session with Småbolagsjakten today
Weiterlesen
2018-11-06
NeoDynamics participates in investor meetings during the IPO
Weiterlesen
2018-11-06
NeoDynamics introduces NeoNavia®, a micropulse biopsy system, to a wider audience in the UK
Weiterlesen
2018-11-01
New technology from NeoDynamics approved for study in Germany
Weiterlesen
2018-10-31
Regulatory
The subscription period in NeoDynamics’ issue of units prior to planned listing on Spotlight Stock Market begins today
Weiterlesen
2018-10-30
Regulatory
NeoDynamics AB (publ) announces approval on passportation of prospectus
Weiterlesen
2018-10-29
Regulatory
NeoDynamics AB (publ) publishes prospectus and enters agreement on additional subscription commitment
Weiterlesen
2018-10-25
Regulatory
NeoDynamics AB (publ) approved for listing on Spotlight Stock Market
Weiterlesen